MedPath
HSA Approval

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

SIN15172P

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

PERIOCLINE PERIODONTAL OINTMENT 2% W/W

February 3, 2017

SUNSTAR SINGAPORE PTE. LTD.

SUNSTAR SINGAPORE PTE. LTD.

Regulatory Information

SUNSTAR SINGAPORE PTE. LTD.

SUNSTAR SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

OINTMENT

**DOSAGE AND ADMINISTRATION** Insert the tip of the applicator in periodontal pockets of each tooth as deeply as possible prior to injecting a sufficient amount of gel to fill the pockets. Approximately 25 mg of gel is administered into pockets of 5 to 7 mm in depth. The treatment starts with applications every 14 days, up to a total of 3 or 4 applications (over 4 to 6 weeks). Then the applications will be made every 3 months.

PERIODONTAL

Medical Information

**INDICATIONS** Periocline® is indicated for the treatment of severe chronic periodontitis in adults. It should be used as an adjunct to conventional scaling and root planing.

**CONTRAINDICATIONS** - Allergy to tetracycline antibiotics. - The use of this drug should be avoided for children less than 8 years of age due to the risk of permanent teeth discoloration and of dental enamel hypoplasia. - Pregnancy and lactation. - Use in association with retinoids.

A01AB23

minocycline

Manufacturer Information

SUNSTAR SINGAPORE PTE. LTD.

Sunstar Inc.

Active Ingredients

Minocycline hydrochloride 21.59mg/g eqv Minocycline

20mg/g

Minocycline

Documents

Package Inserts

PERIOCLINE_SGP PI.pdf

Approved: June 16, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.